Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Oculus Receives China OK for Animal Wound Product

publication date: Nov 16, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Oculus Innovative Sciences of California reported that its partners have received China regulatory approval to market its wound healing solution as an animal product. Based on the company’s Microcyn® technology, Vetericyn™ products speed the healing of wounds while fighting infection. Bayer Animal Health secured the approvals in China and Taiwan. More details...

Stock Symbol: (NSDQ: OCLS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners